Quotes 5-day view Delayed Japan Exchange
06/28/2022
06/29/2022
06/30/2022
07/01/2022
07/03/2022
Date
3105(c)
3055(c)
3050(c)
3035(c)
3060
Last
759 100
1 708 900
1 199 000
757 200
224 400
Volume
+0.81%
-1.61%
-0.16%
-0.49%
+0.82%
Change
Estimated financial data (e) JPY USD
Sales 2022
387 B
2 862 M
2 862 M
Net income 2022
56 627 M
419 M
419 M
Net cash position 2022
348 B
2 573 M
2 573 M
P/E ratio 2022
28,8x
Yield 2022
1,58%
Sales 2023
415 B
3 069 M
3 069 M
Net income 2023
66 237 M
490 M
490 M
Net cash position 2023
372 B
2 751 M
2 751 M
P/E ratio 2023
24,6x
Yield 2023
1,74%
Capitalization
1 631 B
12 062 M
12 062 M
EV / Sales 2022
3,32x
EV / Sales 2023
3,03x
Nbr of Employees
5 752
Free-Float
45,8%
Kyowa Kirin Co., Ltd. (formerly Kyowa Hakko Kirin Co., Ltd.) specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (94.1%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (5.9%).
At the end of 2019, the group had 3...
Ratings of Kyowa Kirin Co. Ltd.
All news about KYOWA KIRIN CO. LTD.
News in other languages on KYOWA KIRIN CO. LTD.
Chart KYOWA KIRIN CO. LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends KYOWA KIRIN CO. LTD.
Short Term Mid-Term Long Term Trends Bullish Neutral Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
3 035,00 JPY
Average target price
3 597,50 JPY
Spread / Average Target
18,5%
Please enable JavaScript in your browser's settings to use dynamic charts.